BR112023020137A2 - Composições, comprimido, estojo e método para tratar e/ou prevenir a inflamação gastrointestinal - Google Patents

Composições, comprimido, estojo e método para tratar e/ou prevenir a inflamação gastrointestinal

Info

Publication number
BR112023020137A2
BR112023020137A2 BR112023020137A BR112023020137A BR112023020137A2 BR 112023020137 A2 BR112023020137 A2 BR 112023020137A2 BR 112023020137 A BR112023020137 A BR 112023020137A BR 112023020137 A BR112023020137 A BR 112023020137A BR 112023020137 A2 BR112023020137 A2 BR 112023020137A2
Authority
BR
Brazil
Prior art keywords
treating
compositions
tablet
gastrointestinal inflammation
preventing gastrointestinal
Prior art date
Application number
BR112023020137A
Other languages
English (en)
Inventor
Mathias Richard
Patrick Boyaval
Sebastien Guery
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Publication of BR112023020137A2 publication Critical patent/BR112023020137A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

composições, comprimido, estojo e método para tratar e/ou prevenir a inflamação gastrointestinal. são proporcionadas aqui composições contendo fungos, p. ex., leveduras, úteis para tratar e/ou prevenir a inflamação gastrointestinal e/ou doenças, disfunções ou condições associadas a ela, em um sujeito com sua necessidade e métodos para usar as mesmas.
BR112023020137A 2021-03-30 2022-03-30 Composições, comprimido, estojo e método para tratar e/ou prevenir a inflamação gastrointestinal BR112023020137A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21165818 2021-03-30
PCT/EP2022/058442 WO2022207721A1 (en) 2021-03-30 2022-03-30 Compositions and methods for treating and preventing gastrointestinal inflammation

Publications (1)

Publication Number Publication Date
BR112023020137A2 true BR112023020137A2 (pt) 2023-11-28

Family

ID=75477864

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023020137A BR112023020137A2 (pt) 2021-03-30 2022-03-30 Composições, comprimido, estojo e método para tratar e/ou prevenir a inflamação gastrointestinal

Country Status (6)

Country Link
US (1) US20240180986A1 (pt)
EP (1) EP4313088A1 (pt)
CN (1) CN117241808A (pt)
AU (1) AU2022251858A1 (pt)
BR (1) BR112023020137A2 (pt)
WO (1) WO2022207721A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0727979T3 (da) 1993-10-22 2001-10-01 Smithkline Beecham Corp Nyt præparat
WO2003011261A1 (en) 2001-08-01 2003-02-13 Medlogic Global Limited Cyanoacrylate monomer-containing antibiotic formulation for topical use
KR20070091613A (ko) 2004-11-08 2007-09-11 그렌마크 파머수티칼스 엘티디. 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물
EP2219655A2 (en) * 2007-11-13 2010-08-25 Biotec Pharmacon ASA Methods of treating or preventing inflammatory diseases of the intestinal tract
AU2019231896A1 (en) * 2018-03-09 2020-10-01 Biohm Health Llc Compositions for use in balancing microbiome

Also Published As

Publication number Publication date
EP4313088A1 (en) 2024-02-07
WO2022207721A1 (en) 2022-10-06
AU2022251858A1 (en) 2023-09-07
US20240180986A1 (en) 2024-06-06
CN117241808A (zh) 2023-12-15

Similar Documents

Publication Publication Date Title
MX2022004874A (es) Compuestos de modulacion de glp-1r.
WO2020102503A3 (en) Fusosome compositions for t cell delivery
WO2019232244A3 (en) Antibody molecules to cd73 and uses thereof
PH12019502004A1 (en) Fungicidal combinations
WO2019178269A3 (en) Antibodies that bind cd39 and uses thereof
NO20082381L (no) Bispesifikke ligander med bindingsspesifisitet til celleoverflate mal og fremgangsmater for anvendelse derav
BR112018012839A2 (pt) composições endofíticas e métodos para melhoramento de traços de plantas em plantas de importância agronômica
EA202191557A1 (ru) Комбинированная терапия радиоиммуноконъюгатами и ингибиторами репарации повреждений днк
GEP20125476B (en) Compositions of antibodies of dickkopf-1 and use thereof
EA201990032A1 (ru) Способы и композиции для терапии посредством потенциирования стволовых клеток
MX2022002489A (es) Composiciones de neurotoxinas para usarse en el tratamiento contra cefalea.
WO2020086857A8 (en) Wdr5 inhibitors and modulators
BR112018069506A2 (pt) métodos para transfectar plantas e para reduzir eventos de integração aleatória
SG10201805233PA (en) Semiconductor Device Including Gates
PH12021550289A1 (en) Ox40-binding polypeptides and uses thereof
MX2021010989A (es) Formulacion que incluye una combinacion de la hormona beta-endorfina y adrenocorticotropica.
WO2020033019A3 (en) Novel mct4 inhibitors and uses thereof
BR112023021913A2 (pt) Tratamento de câncer com inibidor de raf
BR112023020137A2 (pt) Composições, comprimido, estojo e método para tratar e/ou prevenir a inflamação gastrointestinal
WO2019204332A3 (en) Pak4 inhibitors and methods of use
WO2020243627A3 (en) Anti-crispr inhibitors
EP4236077A3 (en) Continuous diffusion configurable standard cell architecture
AU2018288712A1 (en) Methods for treating merkel cell carcinoma (MCC) using NK-92 cells
CL2020003346A1 (es) Métodos para tratar la pérdida de la audición y/o pérdida de la visión asociadas con clrn1
MX2022002853A (es) Composiciones de neurotoxina para uso en el tratamiento de la gastroparesia.